Dendrite Buys Optas for $12 Million

Share this article:
Dendrite International Inc., a provider of sales, marketing and clinical solutions for the pharmaceutical industry, said yesterday that it has acquired Optas Inc. for $12 million.


Founded in 1997, Optas is a privacy-safe database marketing software and services company serving the pharmaceutical and health industries. Optas will become a division of Dendrite International, which is based in Bedminster, NJ.


Dendrite and Optas are already deployed together in a large pharmaceutical company where Optas enables physicians to direct patients into an educational program, and Dendrite provides a personalized patient medical support center where patients speak to medical professionals who complement and support the prescribing doctor's own initiatives. Both elements are orchestrated through Optas' campaign management tool.


Share this article:
close

Next Article in Database Marketing

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Database Marketing

What's H-appending? DiscoverOrg Taps Marketo's Webhooks

What's H-appending? DiscoverOrg Taps Marketo's Webhooks

Cloud-based marketing automation behemoth Marketo joins forces with marketing intelligence company DiscoverOrg to improve its data collection capabilities.

A Toast to Marketing Attribution

A Toast to Marketing Attribution

Vino accessories and storage company Wine Enthusiast indentifies top and underperforming affiliates using algorithmic marketing attribution.

Q&A: When (and How) to Bust Down the Data Door

Q&A: When (and How) to Bust Down the ...

Some people run into issues with trying to build the perfect solution when often an 80% solution will do, says MailChimp's chief data scientist.